3 курс / Фармакология / Интеллектуальные_липидные_наноконтейнеры_в_адресной_доставке_лекарственных

259

carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization. Mol.Ther., 13, 1156-1162.

1068. Boe S., Longva A.S., Hovig E. (2008) Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules.

Oligonucleotides., 18, 123-132.

1069. Boe S., Longva A.S., Hovig E. (2007) Photochemically induced gene silencing using small interfering RNA molecules in combination with lipid carriers. Oligonucleotides., 17, 166-173.

1070. Oliveira S., Fretz M.M., Hogset A., Storm G., Schiffelers R.M. (2007) Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA. Biochim.Biophys.Acta, 1768, 1211-1217.

1071. Engesaeter B.O., Tveito S., Bonsted A., Engebraaten O., Berg K., Maelandsmo G.M. (2006) Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus. J.Gene Med., 8, 707-718.

1072. El Sayed A., Futaki S., Harashima H. (2009) Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS.J., 11, 13-22.

1073. Shiraishi T., Nielsen P.E. (2006) Photochemically enhanced cellular delivery of cell penetrating peptide-PNA conjugates. FEBS Lett., 580, 1451-1456.

1074. Shiraishi T., Nielsen P.E. (2006) Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat.Protoc., 1, 633-636.

1075. Alvarez-Lorenzo C., Deshmukh S., Bromberg L., Hatton T.A., Sandez-Macho I., Concheiro A. (2007) Temperatureand light-responsive blends of pluronic F127 and poly(N,N-dimethylacrylamide-co-methacryloyloxyazobenzene). Langmuir, 23, 11475-11481. 1076. Eastoe J., Sanchez-Dominguez M., Cumber H., Burnett G., Wyatt P., Heenan R.K. (2003) Photoresponsive microemulsions. Langmuir, 19, 6579-6581.

1077. Lee C.T., Smith K.A., Hatton T.A. (2004) Photoreversible viscosity changes and gelation in mixtures of hydrophobically modified polyelectrtolytes and photosensitive surfactants. Macromol., 37, 5397-5405.

1078. Shang T., Smith K.A., Hatton T.A. (2003) Photoresponsive surfactants exhibiting unusually large , reversible surface tension changes under varying illumination conditions. Langmuir, 19, 10764-10773.

1079. El Halabieh R.H., Mermut O., Barrett C.J. (2004) Using light to control physical properties of polymers and surfaces with azobenzene chromophores. Pure.Appl.Chem., 76, 1445-1465.

1080. Tong X., Wang G., Soldera A., Zhao Y. (2005) How can azobenzene block copolymer vesicles be dissociated and reformed by light? J.Phys.Chem.B, 109, 20281-20287.

1081. Deshmukh S., Bromberg L., Smith K.A., Hatton T.A. (2009) Photoresponsive behavior of amphiphilic copolymers of azobenzene and n,n-dimethylacrylamide in aqueous solutions. Langmuir, 25, 3459-3466.

1082. Khoukh S., Oda R., Labrot T., Perrin P., Tribet C. (2007) Light-responsive hydrophobic association of azobenzene-modified poly(acrylic acid) with neutral surfactants. Langmuir, 23, 94-104.

1083. Pouliquen G., Tribet C. (2006) Light-triggered association of bovine serum albumin and azobenzene-modified poly(acrylic acid) in dilute and semidilute solutions. Macromol., 39, 373-383.

1084. Pouliquen G., Amiel C., Tribet C. (2007) Photoresponsive viscosity and host-guest association in aqueous mixtures of poly-cyclodextrin with azobenzene-modified poly(acrylic)acid. J.Phys.Chem.B, 111, 5587-5595.

1085. Jiang J., Tong X., Zhao Y. (2005) A new design for light-breakable polymer micelles. J.Am.Chem.Soc., 127, 8290-8291.

1086. Jiang J., Tong X., Morris D., Zhao Y. (2006) Toward photocontrolled release using light-dissociable block copolymer micelles. Macromol., 39, 4633-4640.

1087. Bisby R.H., Mead C., Morgan C.G. (2000) Wavelength-programmed solute release from photosensitive liposomes. Biochem.Biophys.Res.Commun., 276, 169-173.

1088. Yagai S., Karatsu T., Kitamura A. (2005) Photocontrollable self-assembly. Chemistry., 11, 4054-4063.

260

1089. Bisby R.H., Mead C., Morgan C.G. (2000) Active uptake of drugs into photosensitive liposomes and rapid release on UV photolysis. Photochem.Photobiol., 72, 57-61.

1090. Bisby R.H., Mead C., Mitchell A.C., Morgan C.G. (1999) Fast laser-induced solute release from liposomes sensitized with photochromic lipid: effects of temperature, lipid host, and sensitizer concentration. Biochem.Biophys.Res.Commun., 262, 406-410.

1091. Liu X.M., Yang B., Wang Y.L., Wang J.Y. (2005) Photoisomerisable cholesterol derivatives as photo-trigger of liposomes: effect of lipid polarity, temperature, incorporation ratio, and cholesterol. Biochim.Biophys.Acta, 1720, 28-34.

1092. Ishii K., Hamada T., Hatakeyama M., Sugimoto R., Nagasaki T., Takagi M. (2009) Reversible control of exoand endo-budding transitions in a photosensitive lipid membrane.

Chembiochem., 10, 251-256.

1093. Wang G., Tong X., Zhao Y. (2004) Preparation of azobenzene-containing amphiphilic diblock copolymers for light-responsive micellar aggregates. Macromolecules, 37, 89118917.

1094. Zhao Y. (2009) Photocontrollable block colopymer micelles: what can we control? J.Mater.Chem., 19, 4887-4895.

1095. Lee H.I., Wu W., Oh J.K., Mueller L., Sherwood G., Peteanu L., Kowalewski T., Matyjaszewski K. (2007) Light-induced reversible formation of polymeric micelles.

Angew.Chem.Int.Ed Engl., 46, 2453-2457.

1096. Pincock J.A. (1997) Photochemistry arylmethyl esters in nucleophilic solvents: radical pair and ion pair intermediates. Acc.Chem.Res., 30, 43-49.

1097. Furuta T., Wang S.S., Dantzker J.L., Dore T.M., Bybee W.J., Callaway E.M., Denk W., Tsien R.Y. (1999) Brominated 7-hydroxycoumarin-4-ylmethyls: photolabile protecting groups with biologically useful cross-sections for two photon photolysis.

Proc.Natl.Acad.Sci.U.S.A, 96, 1193-1200.

1098. Zhao Y., Zheng Q., Dakin K., Xu K., Martinez M.L., Li W.H. (2004) New caged coumarin fluorophores with extraordinary uncaging cross sections suitable for biological imaging applications. J.Am.Chem.Soc., 126, 4653-4663.

1099. Jiang Y., Wang Y., Ma N., Wang Z., Smet M., Zhang X. (2007) Reversible selforganization of a UV-responsive PEG-terminated malachite green derivative: vesicle formation and photoinduced disassembly. Langmuir, 23, 4029-4034.

1100. Kang N., Perron M.E., Prud'homme R.E., Zhang Y., Gaucher G., Leroux J.C. (2005) Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. Nano.Lett., 5, 315-319.

1101. Jiang J., Qu B., Lepage M., Zhao Y. (2007) Polymer micelles stabilization on demand through reversible photo-cross-linking. Macromol., 40, 790-792.

1102. Trenor S.R., Shultz A.R., Love B.J., Long T.E. (2004) Coumarins in polymers: from light harvesting to photo-cross-linkable tissue scaffolds. Chem.Rev., 104, 3059-3077.

1103. Trinh X.A., Fukuda J., Adachi Y., Nakanishi H., Norisuye T., Tran-Cong-Miyata Q. (2007) Effects of elastic deformation on phase separation of a polymer blend driven by a reversible photo-cross-linking reaction. Macromol., 40, 5566-5574.

1104. Lendlein A., Jiang H., Junger O., Langer R. (2005) Light-induced shape-memory polymers. Nature, 434, 879-882.

1105. Boron WF, Boulpaep EL: (2002) "Medical physiology: cellular and molecular approach" New York: W.B. Sounders Co..

1106. Guyton AC, Hall JE: (2006) "Textbook of medical physiology" Elsevier. 1107. Lehninger: (2005) "Principles of biochemistry" Worth Publishing.

1108. Voet D, Voet JG: (1995) "Biochemistry" New York: John Wiley&Sons, INC..

1109. Ojugo A.S., McSheehy P.M., McIntyre D.J., McCoy C., Stubbs M., Leach M.O., Judson I.R., Griffiths J.R. (1999) Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous (19)F and (31)P probes. NMR Biomed., 12, 495-504.

1110. Stubbs M., McSheehy P.M., Griffiths J.R., Bashford C.L. (2000) Causes and consequences of tumour acidity and implications for treatment. Mol.Med.Today, 6, 15-19. 1111. Drummond D.C., Zignani M., Leroux J. (2000) Current status of pH-sensitive liposomes in drug delivery. Prog.Lipid Res., 39, 409-460.

261

1112. Gillies E.R., Frechet J.M. (2005) pH-Responsive copolymer assemblies for controlled release of doxorubicin. Bioconjug.Chem., 16, 361-368.

1113. Yatvin M.B., Kreutz W., Horwitz B.A., Shinitzky M. (1980) pH-sensitive liposomes: possible clinical implications. Science, 210, 1253-1255.

1114. Venugopalan P., Jain S., Sankar S., Singh P., Rawat A., Vyas S.P. (2002) pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects. Pharmazie, 57, 659-671.

1115. Duzgunes N., Simoes S., Lopez-Mesas M., Pedroso de Lima M.C., (2007) Intracellular delivery of therapeutic oligonucleotides in pH-sensitive and cationic liposomes. "Liposome technology" New Yourk, London: Informa healthcare; 253-275.

1116. Fattal E., Couvreur P., Dubernet C. (2004) "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes. Adv.Drug Deliv.Rev., 56, 931-946.

1117. Carey FA: (2004) "Organic chemistry" Boston: McGraw-Hill Higher Education. 1118. de Oliveira M.C., Rosilio V., Lesieur P., Bourgaux C., Couvreur P., Ollivon M., Dubernet C. (2000) pH-sensitive liposomes as a carrier for oligonucleotides: a physicochemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biophys.Chem., 87, 127-137.

1119. Hong M.S., Lim S.J., Oh Y.K., Kim C.K. (2002) pH-sensitive, serum-stable and longcirculating liposomes as a new drug delivery system. J.Pharm.Pharmacol., 54, 51-58.

1120. Collins D., Litzinger D.C., Huang L. (1990) Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols. Biochim.Biophys.Acta, 1025, 234-242.

1121. Liu D., Huang L. (1990) pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. Biochim.Biophys.Acta, 1022, 348-354.

1122. Tari A.M., Fuller N., Boni L.T., Collins D., Rand P., Huang L. (1994) Interactions of liposome bilayers composed of 1,2-diacyl-3-succinylglycerol with protons and divalent cations. Biochim.Biophys.Acta, 1192, 253-262.

1123. Drummond D.C., Daleke D.L. (1995) Synthesis and characterization of N-acylated, pH-sensitive 'caged' aminophospholipids. Chem.Phys.Lipids, 75, 27-41.

1124. Mignet N., Richard C., Seguin J., Largeau C., Bessodes M., Scherman D. (2008) Anionic pH-sensitive pegylated lipoplexes to deliver DNA to tumors. Int.J.Pharm., 361, 194201.

1125. Connor J., Huang L. (1986) pH-sensitive immunoliposomes as an efficient and targetspecific carrier for antitumor drugs. Cancer Res., 46, 3431-3435.

1126. Duzgunes N., Straubinger R.M., Baldwin P.A., Friend D.S., Papahadjopoulos D. (1985) Proton-induced fusion of oleic acid-phosphatidylethanolamine liposomes. Biochemistry, 24, 3091-3098.

1127. Straubinger R.M., Duzgunes N., Papahadjopoulos D. (1985) pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett., 179, 148-154. 1128. Bergstrand N., Arfvidsson M.C., Kim J.M., Thompson D.H., Edwards K. (2003) Interactions between pH-sensitive liposomes and model membranes. Biophys.Chem., 104, 361-379.

1129. Turner C., Weir N., Catterall C., Baker T.S., Jones M.N. (2002) The transfection of Jurkat T-leukemic cells by use of pH-sensitive immunoliposomes. J.Liposome Res., 12, 4550.

1130. Leroux J., Roux E., Le Garrec D., Hong K., Drummond D.C. (2001) N- isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J.Control Release, 72, 71-84.

1131. Mizoue T., Horibe T., Maruyama K., Takizawa T., Iwatsuru M., Kono K., Yanagie H., Moriyasu F. (2002) Targetability and intracellular delivery of anti-BCG antibody-modified, pH-sensitive fusogenic immunoliposomes to tumor cells. Int.J.Pharm., 237, 129-137.

1132. Roux E., Francis M., Winnik F.M., Leroux J.C. (2002) Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs. Int.J.Pharm., 242, 25-36. 1133. Connor J., Yatvin M.B., Huang L. (1984) pH-sensitive liposomes: acid-induced liposome fusion. Proc.Natl.Acad.Sci.U.S.A, 81, 1715-1718.

262

1134. Hope M.J., Walker D.C., Cullis P.R. (1983) Ca2+ and pH induced fusion of small unilamellar vesicles consisting of phosphatidylethanolamine and negatively charged phospholipids: a freeze fracture study. Biochem.Biophys.Res.Commun., 110, 15-22.

1135. Straubinger R.M., Hong K., Friend D.S., Papahadjopoulos D. (1983) Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell, 32, 1069-1079.

1136. Holland J.W., Cullis P.R., Madden T.D. (1996) Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry, 35, 26102617.

1137. Slepushkin V.A., Simoes S., Dazin P., Newman M.S., Guo L.S., Pedroso de Lima M.C., Duzgunes N. (1997) Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J.Biol.Chem., 272, 2382-2388.

1138. Kirpotin D., Hong K., Mullah N., Papahadjopoulos D., Zalipsky S. (1996) Liposomes with detachable polymer coating: destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett., 388, 115-118.

1139. Ishida O., Maruyama K., Tanahashi H., Iwatsuru M., Sasaki K., Eriguchi M., Yanagie H. (2001) Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. Pharm.Res., 18, 1042-1048.

1140. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. (1994) The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J.Biol.Chem., 269, 12918-12924.

1141. Simoes S., Slepushkin V., Gaspar R., de Lima M.C., Duzgunes N. (1998) Gene delivery by negatively charged ternary complexes of DNA, cationic liposomes and transferrin or fusigenic peptides. Gene Ther., 5, 955-964.

1142. Stier E.M., Mandal M., Lee K.D. (2005) Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.

Mol.Pharm., 2, 74-82.

1143. Roux E., Lafleur M., Lataste E., Moreau P., Leroux J.C. (2003) On the characterization of pH-sensitive liposome/polymer complexes. Biomacromolecules., 4, 240-248.

1144. Yessine M.A., Leroux J.C. (2004) Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv.Drug Deliv.Rev., 56, 999-1021.

1145. Jones R.A., Cheung C.Y., Black F.E., Zia J.K., Stayton P.S., Hoffman A.S., Wilson M.R. (2003) Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pHsensitive disruption of endosomal vesicles. Biochem.J., 372, 65-75.

1146. Kyriakides T.R., Cheung C.Y., Murthy N., Bornstein P., Stayton P.S., Hoffman A.S. (2002) pH-sensitive polymers that enhance intracellular drug delivery in vivo. J.Control Release, 78, 295-303.

1147. Fujiwara M., Grubbs R.H., Baldeschwieler J.D. (1997) Characterization of pHDependent Poly(acrylic Acid) Complexation with Phospholipid Vesicles. J.Colloid Interface Sci., 185, 210-216.

1148. Kono K., Zenitani K., Takagishi T. (1994) Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups. Biochim.Biophys.Acta, 1193, 1-9.

1149. Couffin-Hoarau A.C., Leroux J.C. (2004) Report on the use of poly(organophosphazenes) for the design of stimuli-responsive vesicles. Biomacromolecules., 5, 2082-2087.

1150. Meyer O., Papahadjopoulos D., Leroux J.C. (1998) Copolymers of N- isopropylacrylamide can trigger pH sensitivity to stable liposomes. FEBS Lett., 421, 61-64. 1151. Zignani M., Drummond D.C., Meyer O., Hong K., Leroux J.C. (2000) In vitro characterization of a novel polymeric-based pH-sensitive liposome system. Biochim.Biophys.Acta, 1463, 383-394.

1152. Tirrell D.A., Takigawa D.Y., Seki K. (1985) pH sensitization of phospholipid vesicles via complexation with synthetic poly(carboxylic acid)s. Ann.N.Y.Acad.Sci., 446, 237-248.

263

1153. Yessine M.A., Lafleur M., Meier C., Petereit H.U., Leroux J.C. (2003) Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers. Biochim.Biophys.Acta, 1613, 28-38.

1154. Yessine M.A., Dufresne M.H., Meier C., Petereit H.U., Leroux J.C. (2007) Protonactuated membrane-destabilizing polyion complex micelles. Bioconjug.Chem., 18, 10101014.

1155. Yessine M.A., Meier C., Petereit H.U., Leroux J.C. (2006) On the role of methacrylic acid copolymers in the intracellular delivery of antisense oligonucleotides.

Eur.J.Pharm.Biopharm., 63, 1-10.

1156. Kono K., Igawa T., Takagishi T. (1997) Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim.Biophys.Acta, 1325, 143-154.

1157. Sakaguchi N., Kojima C., Harada A., Kono K. (2008) Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH. Bioconjug.Chem., 19, 1040-1048.

1158. Thomas J.L., Tirrell D.A. (1992) Polyelectrolyte-sensitized phospholipid vesicles.

Acc.Chem.Res., 25, 336-342.

1159. Kono K., Torikoshi Y., Mitsutomi M., Itoh T., Emi N., Yanagie H., Takagishi T. (2001) Novel gene delivery systems: complexes of fusigenic polymer-modified liposomes and lipoplexes. Gene Ther., 8, 5-12.

1160. Sakaguchi N., Kojima C., Harada A., Koiwai K., Shimizu K., Emi N., Kono K. (2006) Enhancement of transfection activity of lipoplexes by complexation with transferrin-bearing fusogenic polymer-modified liposomes. Int.J.Pharm., 325, 186-190.

1161. Yuba E., Kojima C., Sakaguchi N., Harada A., Koiwai K., Kono K. (2008) Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes. J.Control Release, 130, 77-83.

1162. Francis M.F., Dhara G., Winnik F.M., Leroux J.C. (2001) In vitro evaluation of pHsensitive polymer/niosome complexes. Biomacromolecules., 2, 741-749.

1163. Petriat F., Roux E., Leroux J.C., Giasson S. (2004) Study of molecular interactions between a phospholipidic layer and a pH-sensitive polymer using the Langmuir balance technique. Langmuir, 20, 1393-1400.

1164. Bertrand N., Fleischer J.G., Wasan K.M., Leroux J.C. (2009) Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes. Biomaterials, 30, 2598-2605.

1165. Roux E., Passirani C., Scheffold S., Benoit J.P., Leroux J.C. (2004) Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J.Control Release, 94, 447-451.

1166. Lee E.S., Shin H.J., Na K., Bae Y.H. (2003) Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J.Control Release, 90, 363-374.

1167. Lee E.S., Na K., Bae Y.H. (2003) Polymeric micelle for tumor pH and folate-mediated targeting. J.Control Release, 91, 103-113.

1168. Lee E.S., Na K., Bae Y.H. (2005) Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J.Control Release, 103, 405-418.

1169. Mohajer G., Lee E.S., Bae Y.H. (2007) Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells. Pharm.Res., 24, 1618-1627.

1170. Oh K.T., Lee E.S., Kim D., Bae Y.H. (2008) L-histidine-based pH-sensitive anticancer drug carrier micelle: reconstitution and brief evaluation of its systemic toxicity. Int.J.Pharm., 358, 177-183.

1171. Fundueanu G., Constantin M., Stanciu C., Theodoridis G., Ascenzi P. (2009) pHand temperature-sensitive polymeric microspheres for drug delivery: the dissolution of copolymers modulates drug release. J.Mater.Sci.Mater.Med., 20, 2465-2475.

1172. Hyndman L., Lemoine J.L., Huang L., Porteous D.J., Boyd A.C., Nan X. (2004) HIV- 1 Tat protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J.Control Release, 99, 435-444.

1173. Nori A., Jensen K.D., Tijerina M., Kopeckova P., Kopecek J. (2003) Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells. J.Control Release, 91, 53-59.

264

1174. Pujals S., Fernandez-Carneado J., Lopez-Iglesias C., Kogan M.J., Giralt E. (2006) Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP selfassembly. Biochim. Biophys. Acta, 1758, 264-279.

1175. Kim G.M., Bae Y.H., Jo W.H. (2005) pH-induced micelle formation of poly(histidine- co-phenylalanine)-block-poly(ethylene glycol) in aqueous media. Macromol.Biosci., 5, 11181124.

1176. Sethuraman V.A., Lee M.C., Bae Y.H. (2008) A biodegradable pH-sensitive micelle system for targeting acidic solid tumors. Pharm.Res., 25, 657-666.

1177. Kang S.I., Bae Y.H. (2002) pH-induced solubility transition of sulfonamide-based polymers. J.Control Release, 80, 145-155.

1178. Sethuraman V.A., Bae Y.H. (2007) TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J.Control Release, 118, 216-224. 1179. Lee E.S., Na K., Bae Y.H. (2005) Super pH-sensitive multifunctional polymeric micelle. Nano.Lett., 5, 325-329.

1180. Lee E.S., Gao Z., Kim D., Park K., Kwon I.C., Bae Y.H. (2008) Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance. J.Control Release, 129, 228-236.

1181. Yin H., Lee E.S., Kim D., Lee K.H., Oh K.T., Bae Y.H. (2008) Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b- poly(ethylene glycol) mixed micelles. J.Control Release, 126, 130-138.

1182. Bikram M., West J.L. (2008) Thermo-responsive systems for controlled drug delivery.

Expert.Opin.Drug Deliv., 5, 1077-1091.

1183. Yatvin M.B., Weinstein J.N., Dennis W.H., Blumenthal R. (1978) Design of liposomes for enhanced local release of drugs by hyperthermia. Science, 202, 1290-1293.

1184. Mabrey S., Sturtevant J.M. (1976) Investigation of phase transitions of lipids and lipid mixtures by sensitivity differential scanning calorimetry. Proc.Natl.Acad.Sci.U.S.A, 73, 38623866.

1185. Mills J.K., Needham D. (2005) Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim.Biophys.Acta, 1716, 77-96.

1186. Lindner L.H., Eichhorn M.E., Eibl H., Teichert N., Schmitt-Sody M., Issels R.D., Dellian M. (2004) Novel temperature-sensitive liposomes with prolonged circulation time.

Clin.Cancer Res., 10, 2168-2178.

1187. Lindner L.H., Hossann M., Vogeser M., Teichert N., Wachholz K., Eibl H., Hiddemann W., Issels R.D. (2008) Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release. J.Control Release, 125, 112-120.

1188. Fleer E.A., Unger C., Kim D.J., Eibl H. (1987) Metabolism of ether phospholipids and analogs in neoplastic cells. Lipids, 22, 856-861.

1189. Kotting J., Berger M.R., Unger C., Eibl H. (1992) Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother. Pharmacol., 30, 105-112.

1190. Mollinedo F., Fernandez-Luna J.L., Gajate C., Martin-Martin B., Benito A., MartinezDalmau R., Modolell M. (1997) Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). Cancer Res., 57, 1320-1328.

1191. Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., Verheij M. (1999) Alkyllysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res., 59, 2457-2463.

1192. Ruiter G.A., Zerp S.F., Bartelink H., van Blitterswijk W.J., Verheij M. (2003) Anticancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs, 14, 167-173.

1193. van Blitterswijk W.J., Verheij M. (2008) Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr.Pharm.Des, 14, 2061-2074.

1194. Oberle C., Massing U., Krug H.F. (2005) On the mechanism of alkylphosphocholine (APC)-induced apoptosis in tumour cells. Biol.Chem., 386, 237-245.

265

1195. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., Junge K., Bryceson A., Berman J. (2002) Oral miltefosine for Indian visceral leishmaniasis. N.Engl.J.Med., 347, 1739-1746.

1196. Leonard R., Hardy J., van Tienhoven G., Houston S., Simmonds P., David M., Mansi J. (2001) Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J.Clin.Oncol., 19, 4150-4159.

1197. Collini P., Premchand N., Lockwood D., Greig J. (2009) Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.

Ann.Trop.Med.Parasitol., 103, 455-459.

1198. Chugh P., Bradel-Tretheway B., Monteiro-Filho C.M., Planelles V., Maggirwar S.B., Dewhurst S., Kim B. (2008) Akt inhibitors as an HIV-1 infected macrophage-specific antiviral therapy. Retrovirology., 5, 11.

1199. Papagiannaros A., Hatziantoniou S., Lelong-Rebel I.H., Papaioannou G.T., Dimas K., Demetzos C. (2006) Antitumor activity of doxorubicin encapsulated in hexadecylphosphocholine (HePC) liposomes against human xenografts on Scid mice. In Vivo, 20, 129-135.

1200. Papagiannaros A., Hatziantoniou S., Dimas K., Papaioannou G.T., Demetzos C. (2006) A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines.

Biomed.Pharmacother., 60, 36-42.

1201. Aguilar M.R., Elvira C., Gallardo A., Vazquez B., Roman J.S., (2007) Smart polymers and their applications as biomaterials. "Biomaterials" Ashammakhi N., Reis R., Chiellini E.1- 26.

1202. Yoshida R., Sakai K., Okano T., Sakurai Y. (1994) Modulating the phase transition temperature and thermosensitivity in N-isopropylacrylamide copolymer gels.

J.Biomater.Sci.Polym.Ed, 6, 585-598.

1203. Zhang X., Zhuo R., Yang Y. (2002) Using mixed solvent to synthesize temperature sensitive poly(N-isopropylacrylamide) gel with rapid dynamics properties. Biomaterials, 23, 1313-1318.

1204. Naha P.C., Casey A., Tenuta T., Lynch I., Dawson K.A., Byrne H.J., Davoren M. (2009) Preparation, characterization of NIPAM and NIPAM/BAM copolymer nanoparticles and their acute toxicity testing using an aquatic test battery. Aquat.Toxicol., 92, 146-154.

1205. Qiu Y., Park K. (2001) Environment-sensitive hydrogels for drug delivery. Adv.Drug Deliv.Rev., 53, 321-339.

1206. Mackinnon N., Guerin G., Liu B., Gradinaru C.C., Macdonald P.M. (2009) Liposomehydrogel bead complexes prepared via biotin-avidin conjugation. Langmuir, 25, 9413-9423. 1207. de Olivera A.M., de Olivera P.C., dos Santos A.M., Zanin M.H.A., Re M.I. (2009) Synthesis and characterization of thermo-responsive particles of poly(hydroxybutirate-co- hydroxyvalerate)-b-poly(N-isopropylacrylamide). Braz.J.Phys., 39, 217-222.

1208. Kjoniksen A.L., Zhu K., Pamies R., Nystrom B. (2008) Temperature-induced formation and contraction of micelle-like aggregates in aqueous solutions of thermoresponsive short-chain copolymers. J.Phys.Chem.B, 112, 3294-3299.

1209. Liu Y., Cao X., Luo M., Le Z., Xu W. (2009) Self-assembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release. J.Colloid Interface Sci., 329, 244-252.

1210. Lv S., Liu L., Yang W. (2009) Preparation of Soft Hydrogel Nanoparticles with PNIPAm Hair and Characterization of Their Temperature-Induced Aggregation. Langmuir. 1211. Wei H., Cheng C., Chang C., Chen W.Q., Cheng S.X., Zhang X.Z., Zhuo R.X. (2008) Synthesis and applications of shell cross-linked thermoresponsive hybrid micelles based on poly(N-isopropylacrylamide-co-3-(trimethoxysilyl)propyl methacrylate)-b-poly(methyl methacrylate). Langmuir, 24, 4564-4570.

1212. Qiu L.Y., Wu X.L., Jin Y. (2009) Doxorubicin-loaded polymeric micelles based on amphiphilic polyphosphazenes with poly(N-isopropylacrylamide-co-N,N- dimethylacrylamide) and ethyl glycinate as side groups: synthesis, preparation and in vitro evaluation. Pharm.Res., 26, 946-957.

266

1213. Jiang J., Hua D., Tang J. (2009) One-Pot Synthesis of pHand Thermo-Sensitive Chitosan-Based Nanoparticles by the Polymerization of Acrylic Acid/Chitosan with MacroRAFT Agent. Int.J.Biol.Macromol., 46, 126-130.

1214. Qu T., Wang A., Yuan J., Gao Q. (2009) Preparation of an amphiphilic triblock copolymer with pHand thermo-responsiveness and self-assembled micelles applied to drug release. J.Colloid Interface Sci., 336, 865-871.

1215. Qu T., Wang A., Yuan J., Shi J., Gao Q. (2009) Preparation and characterization of thermo-responsive amphiphilic triblock copolymer and its self-assembled micelle for controlled drug release. Colloids Surf.B Biointerfaces., 72, 94-100.

1216. Akimoto J., Nakayama M., Sakai K., Okano T. (2009) Temperature-induced intracellular uptake of thermoresponsive polymeric micelles. Biomacromolecules., 10, 13311336.

1217. Soga O., van Nostrum C.F., Hennink W.E. (2005) Thermosensitive and biodegradable polymeric micelles with transient stability. J.Control Release, 101, 383-385.

1218. Soga O., van Nostrum C.F., Fens M., Rijcken C.J., Schiffelers R.M., Storm G., Hennink W.E. (2005) Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. J.Control Release, 103, 341-353.

1219. Soga O., van Nostrum C.F., Ramzi A., Visser T., Soulimani F., Frederik P.M., Bomans P.H., Hennink W.E. (2004) Physicochemical characterization of degradable thermosensitive polymeric micelles. Langmuir, 20, 9388-9395.

1220. Soga O., van Nostrum C.F., Hennink W.E. (2004) Poly(N-(2-hydroxypropyl) methacrylamide mono/di lactate): a new class of biodegradable polymers with tuneable thermosensitivity. Biomacromolecules., 5, 818-821.

1221. Huang S.L. (2008) Liposomes in ultrasonic drug and gene delivery. Adv.Drug Deliv.Rev., 60, 1167-1176.

1222. O'Brien W.D., Jr. (2007) Ultrasound-biophysics mechanisms. Prog.Biophys.Mol.Biol., 93, 212-255.

1223. Unger E.C., Zutshi R., Matsunaga T.O., Ramaswami R., (2006) Lipid-coated submicron-sized particles as drug carriers. "Nanoparticulates as drug carriers" Torchilin V. London: Imperial College Press; 225-254.

1224. Newman C.M., Bettinger T. (2007) Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther., 14, 465-475.

1225. Chromas J.E., Dayton P., May D., Ferrara K.W. (2001) Threshold of fragmentation for ultrasonic contrast agents. J.Biomed.Optics., 6, 141-150.

1226. Unger E.C., Porter T., Culp W., Labell R., Matsunaga T., Zutshi R. (2004) Therapeutic applications of lipid-coated microbubbles. Adv.Drug Deliv.Rev., 56, 1291-1314.

1227. Church C.C. (2002) Spontaneous homogeneous nucleation, inertial cavitation and the safety of diagnostic ultrasound. Ultrasound Med.Biol., 28, 1349-1364.

1228. Yang X., Church C.C. (2005) A model for the dynamics of gas bubbles in soft tissue.

J.Acoust.Soc.Am., 118, 3595-3606.

1229. Huang S.L., McPherson D.D., MacDonald R.C. (2008) A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery. Ultrasound Med.Biol., 34, 1272-1280.

1230. Buchanan K.D., Huang S., Kim H., MacDonald R.C., McPherson D.D. (2008) Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. J.Pharm.Sci., 97, 2242-2249.

1231. Dijkmans P.A., Juffermans L.J., Musters R.J., van Wamel A., ten Cate F.J., van Gilst W., Visser C.A., de Jong N., Kamp O. (2004) Microbubbles and ultrasound: from diagnosis to therapy. Eur.J.Echocardiogr., 5, 245-256.

1232. Dayton P.A., Chomas J.E., Lum A.F., Allen J.S., Lindner J.R., Simon S.I., Ferrara K.W. (2001) Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys.J., 80, 1547-1556.

1233. Lindner J.R., Song J., Xu F., Klibanov A.L., Singbartl K., Ley K., Kaul S. (2000) Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation, 102, 2745-2750.

267

1234. Lindner J.R., Dayton P.A., Coggins M.P., Ley K., Song J., Ferrara K., Kaul S. (2000) Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation, 102, 531-538.

1235. Lindner J.R., Song J., Christiansen J., Klibanov A.L., Xu F., Ley K. (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation, 104, 2107-2112.

1236. Naito Y., Ito M., Watanabe T., Suzuki H. (2005) Biomarkers in patients with gastric inflammation: a systematic review. Digestion, 72, 164-180.

1237. Willmann J.K., Cheng Z., Davis C., Lutz A.M., Schipper M.L., Nielsen C.H., Gambhir S.S. (2008) Targeted microbubbles for imaging tumor angiogenesis: assessment of wholebody biodistribution with dynamic micro-PET in mice. Radiology, 249, 212-219.

1238. Willmann J.K., Paulmurugan R., Chen K., Gheysens O., Rodriguez-Porcel M., Lutz A.M., Chen I.Y., Chen X., Gambhir S.S. (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology, 246, 508-518.

1239. Korpanty G., Chen S., Shohet R.V., Ding J., Yang B., Frenkel P.A., Grayburn P.A. (2005) Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther., 12, 1305-1312.

1240. Weller G.E., Wong M.K., Modzelewski R.A., Lu E., Klibanov A.L., Wagner W.R., Villanueva F.S. (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res., 65, 533-539.

1241. Andonian S., Coulthard T., Smith A.D., Singhal P.S., Lee B.R. (2009) Real-time quantitation of renal ischemia using targeted microbubbles: in-vivo measurement of P-selectin expression. J.Endourol., 23, 373-378.

1242. Fatar M., Stroick M., Griebe M., Alonso A., Kreisel S., Kern R., Hennerici M., Meairs S. (2008) Effect of combined ultrasound and microbubbles treatment in an experimental model of cerebral ischemia. Ultrasound Med.Biol., 34, 1414-1420.

1243. Jing X.X., Wang Z.G., Ran H.T., Li L., Wu X., Li X.D., Peng X.Q., Yang C.J., Li X.S., Zhang Q.X. (2008) Evaluation of renal ischemia-reperfusion injury in rabbits using microbubbles targeted to activated neutrophils. Clin.Imaging, 32, 178-182.

1244. Title L.M., Iles S.E., Gardner M.J., Penney C.J., Clements J.C., Horacek B.M. (2003) Quantitative assessment of myocardial ischemia by electrocardiographic and scintigraphic imaging. J.Electrocardiol., 36, 17-26.

1245. Bernacki J., Dobrowolska A., Nierwinska K., Malecki A. (2008) Physiology and pharmacological role of the blood-brain barrier. Pharmacol.Rep., 60, 600-622.

1246. Sandoval K.E., Witt K.A. (2008) Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol.Dis., 32, 200-219.

1247. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. (2006) Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

J.Neuroimmune.Pharmacol., 1, 223-236.

1248. Ebinger M., Uhr M. (2006) ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response. Eur.Arch.Psychiatry Clin.Neurosci., 256, 294-298. 1249. Begley D.J. (2004) ABC transporters and the blood-brain barrier. Curr.Pharm.Des, 10, 1295-1312.

1250. Garcia-Garcia E., Andrieux K., Gil S., Couvreur P. (2005) Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int.J.Pharm., 298, 274-292.

1251. Kerza-Kwiatecki A.P., Amini S. (1999) CNS as an HIV-1 reservoir; BBB and drug delivery. J.Neurovirol., 5, 113-114.

1252. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. (2003) Non-invasive opening of BBB by focused ultrasound. Acta Neurochir.Suppl, 86, 555-558.

1253. Giesecke T., Hynynen K. (2003) Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. Ultrasound Med.Biol., 29, 1359-1365.

1254. Meairs S., Alonso A. (2007) Ultrasound, microbubbles and the blood-brain barrier.

Prog.Biophys.Mol.Biol., 93, 354-362.

1255. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology, 220, 640-646.

268

1256. Juffermans L.J., Meijering D.B., van Wamel A., Henning R.H., Kooiman K., Emmer M., de Jong N., van Gilst W.H., Musters R., Paulus W.J., van Rossum A.C., Deelman L.E., Kamp O. (2009) Ultrasound and microbubble-targeted delivery of therapeutic compounds: ICIN Report Project 49: Drug and gene delivery through ultrasound and microbubbles.

Neth.Heart J., 17, 82-86.

1257. Park K. (2008) Ultrasound-activatable drug-loaded microbubbles for intracellular targeting. J.Control Release, 132, 151.

1258. Kee P.H., Abruzzo T.A., Smith D.A., Kopechek J.A., Wang B., Huang S.L., MacDonald R.C., Holland C.K., McPherson D.D. (2008) Synthesis, acoustic stability, and pharmacologic activities of papaverine-loaded echogenic liposomes for ultrasound controlled drug delivery. J.Liposome Res., 18, 263-277.

1259. Hernot S., Klibanov A.L. (2008) Microbubbles in ultrasound-triggered drug and gene delivery. Adv.Drug Deliv.Rev., 60, 1153-1166.

1260. Bull J.L. (2007) The application of microbubbles for targeted drug delivery.

Expert.Opin.Drug Deliv., 4, 475-493.

1261. Kheirolomoom A., Dayton P.A., Lum A.F., Little E., Paoli E.E., Zheng H., Ferrara K.W. (2007) Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J.Control Release, 118, 275-284.

1262. Liu Y., Miyoshi H., Nakamura M. (2006) Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J.Control Release, 114, 89-99.

1263. Korpanty G., Carbon J.G., Grayburn P.A., Fleming J.B., Brekken R.A. (2007) Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.

Clin.Cancer Res., 13, 323-330.

1264. Imada T., Tatsumi T., Mori Y., Nishiue T., Yoshida M., Masaki H., Okigaki M., Kojima H., Nozawa Y., Nishiwaki Y., Nitta N., Iwasaka T., Matsubara H. (2005) Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler.Thromb.Vasc.Biol., 25, 2128-2134.

1265. Rychak J.J., Klibanov A.L., Hossack J.A. (2005) Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans.Ultrason.Ferroelectr.Freq. Control, 52, 421-433.

1266. Meijering B.D., Henning R.H., van Gilst W.H., Gavrilovic I., van Wamel A., Deelman L.E. (2007) Optimization of ultrasound and microbubbles targeted gene delivery to cultured primary endothelial cells. J.Drug Target, 15, 664-671.

1267. Shen Z.P., Brayman A.A., Chen L., Miao C.H. (2008) Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther., 15, 1147-1155.

1268. Vandenbroucke R.E., Lentacker I., Demeester J., De Smedt S.C., Sanders N.N. (2008) Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J.Control Release, 126, 265-273.

1269. Tachibana K., Tachibana S. (1995) Albumin microbubble echo-contrast material as an enhancer for ultrasound accelerated thrombolysis. Circulation, 92, 1148-1150.

1270. Shaw G.J., Meunier J.M., Huang S.L., Lindsell C.J., McPherson D.D., Holland C.K. (2009) Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb.Res., 124, 306-310.

1271. Everbach E.C., Francis C.W. (2000) Cavitational mechanisms in ultrasoundaccelerated thrombolysis at 1 MHz. Ultrasound Med.Biol., 26, 1153-1160.

1272. Tsutsui J.M., Grayburn P.A., Xie F., Porter T.R. (2004) Drug and gene delivery and enhancement of thrombolysis using ultrasound and microbubbles. Cardiol.Clin., 22, 299-312. 1273. Klegerman M.E., Zou Y., McPherson D.D. (2008) Fibrin targeting of echogenic liposomes with inactivated tissue plasminogen activator. J.Liposome Res., 18, 95-112.

1274. Molina C.A., Ribo M., Rubiera M., Montaner J., Santamarina E., Delgado-Mederos R., Arenillas J.F., Huertas R., Purroy F., Delgado P., Alvarez-Sabin J. (2006) Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke, 37, 425-429.